»ó´Ü¿©¹é
±â»ç (Àüü 210°Ç)
[Interview] 3Á¦º´¿ë ´Ùº¯È­·Î DPP-4i+TZD Á¶ÇÕ ÀçÁ¶¸í THE MOST 2023-11-07 19:16
[Interview] Áß°­µµ ½ºÅ¸Æ¾+¿¡Á¦Æ¼¹Ìºê,
°í°­µµ ½ºÅ¸Æ¾ ´ëºñ
CVD ¿¹¹æ¡¤NODM¡¤¾à¹°Áß´Ü ¸é¿¡¼­ À̵æ ÈξÀ Ä¿
THE MOST 2023-10-04 17:09
[Expert Opinion] ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á¸¦ À§ÇÑ ¸ð´ÏÅ͸µ Áֱ⠾մç°Ü¾ß THE MOST 2023-10-04 17:04
[Expert Opinion] ´Ù¾àÁ¦ º¹¿ë ȯÀÚ¿¡¼­ µµ³×ÆäÁú ÆÐÃëÁ¦ÀÇ 1Â÷Ä¡·á Àû¿ë THE MOST 2023-09-06 10:42
[Conference Report] ¾à¹° Çϳª·Î ºñ¸¸¡¤½ÉºÎÀü µ¿½Ã°ø·« °¡´É¼º¡è THE MOST 2023-09-04 15:03
¶óÀÎ
[Sub Story] À§¿°Ä¡·á¿¡ ÀÖ¾î Àú¿ë·® PPIsÀÇ ¿ªÇÒ°ú Ä¡·áÀü·«
New Option for Treatment Escorten meeting
THE MOST 2023-08-07 15:25
[Expert Opinion] ARB + ÀÌ´¢Á¦ ÀÓ»ó Àû¿ëÀü·« :
·Î»ç¸£Åº + Ŭ·Î¸£Å»¸®µ·À» Áß½ÉÀ¸·Î
THE MOST 2023-07-05 15:11
[Expert Opinion] ±¹³» ´ç´¢º´ Ä¡·á½ÃÀåÀÇ º¯È­¿Í DPP-4i/SGLT-2iÀÇ ÀÓ»óÀû¿ë THE MOST 2023-07-05 14:45
[Sub Story] 1Â÷ÀÇ·á±â°ü¿¡¼­ SGLT-2¾ïÁ¦Á¦ÀÇ Àû¿ëÀü·« THE MOST 2023-06-05 12:33
[Expert Opinion] ´ç´¢º´ ¸®¾ó¿ùµå °ü¸®Àü·« THE MOST 2023-04-03 15:17
¶óÀÎ
[Expert Opinion] ±¹³»¿Ü °¡À̵å¶óÀÎ ¡®Chlorthalidone¡¯ ¿ì¼± ±Ç°í ÇÑ ¸ñ¼Ò¸® THE MOST 2023-03-10 16:58
[Interview] ±¹³» ÃÖÃÊ SGLT-2¾ïÁ¦Á¦ À̳ªº¸±Û¸®Ç÷ÎÁø THE MOST 2023-03-10 15:53
[Expert Opinion] SGLT-2¾ïÁ¦Á¦ÀÇ ÃÖ½ÅÁö°ß - ½ÅºÎÀü(Kidney Failure) THE MOST 2023-03-10 14:03
[Expert Opinion] SGLT-2¾ïÁ¦Á¦ÀÇ ÃÖ½ÅÁö°ß - ½ÉºÎÀü(Heart Failure) THE MOST 2023-02-07 10:23
[Expert Opinion] SGLT-2i¡¤GLP-1RA¡¤TZD Ä¡·áÀü·«À¸·Î ±â´ë THE MOST 2023-02-07 09:57
¶óÀÎ
[Expert Opinion] ±¹³» Áö¹æ°£Áúȯ ÇöȲÀÇ Æ¯Â¡ THE MOST 2023-02-07 09:57
[Conference Report] EASD 2022: ADA/EASD Consensus Report & UKPDS THE MOST 2022-12-05 15:14
[Primary Expert Opinion] [1Â÷ ÀÇ·á±â°ü ½ÃÁ¡ÀÇ ½ÇÁúÀûÀÎ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®Àü·«]

ȯÀÚº° LDL-C ¸ñÇ¥¼³Á¤ Çʿ䡦º¹¿ë¼øÀÀµµ °³¼±¿¡µµ ½Å°æ½á¾ß

THE MOST 2022-11-16 11:33
[Interview] ¡°°Ç°­°ËÁøÀ² °¡Àå ³·Àº Á¦ÁÖµµ¹Î Æò»ý ÁÖÄ¡ÀÇ »ç¸í ´ÙÇÒ °Í¡± THE MOST 2022-11-16 11:29
[Primary Expert Opinion] [1Â÷ÀÇ·á±â°ü ½ÃÁ¡ÀÇ ½ÇÁúÀûÀÎ ½ÉºÎÀü À̽´]
1Â÷ÀÇ·á±â°ü, ½ÉºÎÀü °ü¸®ÇÒ ¼ö ÀÖ´Ù
THE MOST 2022-10-05 19:05
Back to Top